Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional bleomycin plus triamcinolone for keloids
IRCT20221209056760N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bleomycin and triamcinolone in keloid, sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
bleomycintriamcinolone
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT20221209056760N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221209056760N1.